Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States
Open Access
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 27 (8) , 679.e1-679.e8
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- Merck Sharp and Dohme United Kingdom
- Health Resources and Services Administration (HHSH250201700006C, N00014-20-1-2705, N00014-20-1-2832)
- Angiocrine Bioscience
- Intel Corporation
- Kyowa Kirin Pharmaceutical Development
- Amgen
- CSL Behring
- National Cancer Institute
- Medical College of Wisconsin
- Celgene
- National Institutes of Health
- AbbVie
- Office of Naval Research
- U.S. Public Health Service (U24CA076518)
- National Heart, Lung, and Blood Institute
- Daiichi-Sankyo
- Astellas Pharma US
- Gilead Sciences
This publication has 33 references indexed in Scilit:
- Limitations in health care access and utilization among long‐term survivors of adolescent and young adult cancerCancer, 2012
- Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)Blood, 2011
- Unemployment Among Adult Survivors of Childhood CancerMedical Care, 2010
- Quality of life concerns and depression among hematopoietic stem cell transplant survivorsSupportive Care in Cancer, 2010
- Hematopoietic Stem Cell TransplantationA Global PerspectiveJAMA, 2010
- Prospective predictors of return to work in the 5 years after hematopoietic cell transplantationJournal of Cancer Survivorship, 2009
- Quality of life and social integration after allogeneic hematopoietic SCTBone Marrow Transplantation, 2008
- Recovery and Long-term Function After Hematopoietic Cell Transplantation for Leukemia or LymphomaJAMA, 2004
- Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantationBritish Journal of Haematology, 2001
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974